ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975